Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

Article  Google Scholar 

Zou H, Zhu CZ, Wang C, Wang ZS, Ma X, Han B, Wu LQ. Recurrence of barcelona clinic liver cancer stage A hepatocellular carcinoma after hepatectomy. Am J Med Sci. 2017;354:262–7. https://doi.org/10.1016/j.amjms.2017.05.014.

Article  ADS  PubMed  Google Scholar 

Watanabe M, Hatakeyama S. TRIM proteins and diseases. J Biochem. 2017;161:135–44. https://doi.org/10.1093/jb/mvw087.

Article  CAS  PubMed  Google Scholar 

Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, et al. The tripartite motif family identifies cell compartments. Embo J. 2001;20:2140–51. https://doi.org/10.1093/emboj/20.9.2140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sho T, Tsukiyama T, Sato T, Kondo T, Cheng J, Saku T, Asaka M, Hatakeyama S. TRIM29 negatively regulates p53 via inhibition of Tip60. Biochim Biophys Acta. 2011;1813:1245–53. https://doi.org/10.1016/j.bbamcr.2011.03.018.

Article  CAS  PubMed  Google Scholar 

Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, et al. Loss of TRIM29 alters keratin distribution to promote cell invasion in squamous cell carcinoma. Cancer Res. 2018;78:6795–806. https://doi.org/10.1158/0008-5472.CAN-18-1495.

Article  CAS  PubMed  Google Scholar 

Yang Y, Li Q, Guo L. MicroRNA-122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro. Mol Med Rep. 2018;17:8244–52. https://doi.org/10.3892/mmr.2018.8894.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li F, Liang J, Bai L. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomed Pharmacother. 2018;103:782–9. https://doi.org/10.1016/j.biopha.2018.04.101.

Article  CAS  PubMed  Google Scholar 

Wang C, Zhou Y, Chen B, Yuan W, Huang J. Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection. Oncol Lett. 2018;15:5792–8. https://doi.org/10.3892/ol.2018.8059.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang C, Dong H, Miao C, Zhu J, Wang J, Li P, Li J, Wang Z. TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis. Oncotarget. 2018;9:12323–32. https://doi.org/10.18632/oncotarget.23617.

Article  PubMed  Google Scholar 

Li W, Xue H, Li Y, Li P, Ma F, Liu M, Kong S. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3beta/Wnt/beta-catenin signalling. Clin Exp Pharmacol Physiol. 2019;46:845–53. https://doi.org/10.1111/1440-1681.13119.

Article  CAS  PubMed  Google Scholar 

Xu M, Hu J, Zhou B, Zhong Y, Lin N, Xu R. TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/beta-catenin signaling pathway. Acta Biochim Biophys Sin. 2019;51:68–77. https://doi.org/10.1093/abbs/gmy151.

Article  CAS  PubMed  Google Scholar 

Wang Y, Gao X, Ru X, Sun P, Wang J. A hybrid feature selection algorithm and its application in bioinformatics. Peerj Comput Sci. 2022;8:e933. https://doi.org/10.7717/peerj-cs.933.

Article  PubMed  PubMed Central  Google Scholar 

Shi L, Xiao R, Wang M, Zhang M, Weng N, Zhao X, Zheng X, Wang H, Mai S. MicroRNA-342-3p suppresses proliferation and invasion of nasopharyngeal carcinoma cells by directly targeting Cdc42. Oncol Rep. 2018;40:2750–7. https://doi.org/10.3892/or.2018.6642.

Article  CAS  PubMed  Google Scholar 

Mai S, Xiao R, Shi L, Zhou X, Yang T, Zhang M, Weng N, Zhao X, Wang R, Liu J, et al. MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma. Cell Death Dis. 2019;10:819. https://doi.org/10.1038/s41419-019-2060-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Xu R, Mai SJ, Ma YS, Zhang MY, Cao PS, Weng NQ, Wang RQ, Cao D, Wei W, et al. LncRNA CSMD1-1 promotes the progression of hepatocellular carcinoma by activating MYC signaling. Theranostics. 2020;10:7527–44. https://doi.org/10.7150/thno.45989.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiao HY, Zhang Q, Wang JM, Jiang JY, Huyan LY, Yan J, Li C, Wang HQ. TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer. Cancer Lett. 2022;529:85–99. https://doi.org/10.1016/j.canlet.2021.12.029.

Article  CAS  PubMed  Google Scholar 

Hao L, Zhang Q, Qiao HY, Zhao FY, Jiang JY, Huyan LY, Liu BQ, Yan J, Li C, Wang HQ. TRIM29 alters bioenergetics of pancreatic cancer cells via cooperation of miR-2355–3p and DDX3X recruitment to AK4 transcript. Mol Ther Nucl Acids. 2021;24:579–90. https://doi.org/10.1016/j.omtn.2021.01.027.

Article  CAS  Google Scholar 

Liu Y, Mi Y, Mueller T, Kreibich S, Williams EG, Van Drogen A, Borel C, Frank M, Germain PL, Bludau I, et al. Multi-omic measurements of heterogeneity in HeLa cells across laboratories. Nat Biotechnol. 2019;37:314–22. https://doi.org/10.1038/s41587-019-0037-y.

Article  CAS  PubMed  Google Scholar 

Smits J, Dirks R, Qu J, Oortveld M, Brinkman AB, Zeeuwen P, Schalkwijk J, Zhou H, Marks H, van den Bogaard EH. Terminal keratinocyte differentiation in vitro is associated with a stable DNA methylome. Exp Dermatol. 2021;30:1023–32. https://doi.org/10.1111/exd.14153.

Article  CAS  PubMed  Google Scholar 

Ai L, Kim WJ, Alpay M, Tang M, Pardo CE, Hatakeyama S, May WS, Kladde MP, Heldermon CD, Siegel EM, et al. TRIM29 suppresses TWIST1 and invasive breast cancer behavior. Cancer Res. 2014;74:4875–87. https://doi.org/10.1158/0008-5472.CAN-13-3579.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi SK, Pandiyan K, Eun JW, Yang X, Hong SH, Nam SW, Jones PA, Liang G, You JS. Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29. Oncotarget. 2017;8:98322–35. https://doi.org/10.18632/oncotarget.21681.

Article  PubMed  PubMed Central  Google Scholar 

Sun J, Zhang T, Cheng M, Hong L, Zhang C, Xie M, Sun P, Fan R, Wang Z, Wang L, et al. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/beta-catenin signaling pathway. J Exp Clin Cancer Res. 2019;38:104. https://doi.org/10.1186/s13046-019-1098-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu W, Chen B, Ke D, Chen X. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin. Aging (Albany, NY). 2020;12:13488–501. https://doi.org/10.18632/aging.103451.

Article  CAS  PubMed  Google Scholar 

Xu R, Hu J, Zhang T, Jiang C, Wang HY. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/beta-catenin pathway in cervical cancer. Oncotarget. 2016;7:28579–91. https://doi.org/10.18632/oncotarget.8686.

Article  PubMed  PubMed Central  Google Scholar 

Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY, Mai SJ. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway. Oncotarget. 2016;7:13634–50. https://doi.org/10.18632/oncotarget.7215.

Article  PubMed  PubMed Central  Google Scholar 

Karami FM, Ebrahimi M, Nourbakhsh E, Zia HA, Mirzaei A, Shafieyari S, Salehi A, Hoseinzadeh M, Payandeh Z, Barati G. PI3K/Akt/mTOR signaling pathway in cancer stem cells. Pathol Res Pract. 2022;237:154010. https://doi.org/10.1016/j.prp.2022.154010.

Article  CAS  Google Scholar 

Huang B, Lang X, Li X. The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177. https://doi.org/10.3389/fonc.2022.1023177.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu J, Li Z, Su Q, Zhao J, Ma J. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway. Oncol Rep. 2017;37:1555–64. https://doi.org/10.3892/or.2017.5364.

Article  ADS  CAS  PubMed  Google Scholar 

Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, Chen J, Lane WS, Seto E. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol. 2010;30:3004–15. https://doi.org/10.1128/MCB.01023-09.

Article  CAS  PubMed  PubMed Central  Google Scholar